ZipLine Medical raised $4.3 million in a Series C financing round, led by Boston based-venture capital firm RA Capital Management.
Campbell, Calif.-based ZipLine develops and markets low-cost, non-invasive surgical skin closure devices, an alternative to using staples. The company hopes to cut down on surgical site-related infection through its method.
Additional funds came from XSeed Capital and Claremont Creek Ventures, according to a press release. The company is dedicating the funds to expanding sales and marketing efforts for its ZipLine Surgical Skin Closure product.
“For closing a surgical wound, ZipLine offers the cosmetic outcomes of a good suturing and the simplicity and speed of stapling, so doctors and patients are happy. Anyone can apply it to the patient, not just a surgeon, and the patient can take it off like a band-aid once the healing is done instead of going back in for another expensive medical visit to have staples or sutures removed, so payors are happy,” RA Capital managing director Peter Kolchinsky said in prepared remarks.
